A recent study suggests that using artificial intelligence to measure tumor size could reduce treatment failures by more than 70%.
A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...
News Medical on MSN7d
Artificial intelligence tool helps predict who will benefit from focal therapy for prostate cancerA study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...
Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation ...
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...
Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to provide updated data confirming efficacy ...
Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma ...
MyNewsLA.com on MSN7d
UCLA Health Study Claims AI Can Predict Success of Prostate Cancer TreatmentA new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...
News-Medical.Net on MSN18h
New insights into therapy resistance in breast cancerA new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...
Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, favorable biodistribution and low uptake in non-target organs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback